Literature DB >> 22261508

Clinical sepsis in neonates and young infants, United States, 1988-2006.

Susan L Lukacs1, Stephanie J Schrag.   

Abstract

OBJECTIVE: To describe the burden and characteristics of clinical neonatal sepsis in the United States and evaluate incidence rates after the issuance of intrapartum antibiotic prophylaxis (IAP) guidelines. STUDY
DESIGN: This is a cross-sectional study of hospitalizations of infants aged <3 months diagnosed with sepsis from the 1988-2006 National Hospital Discharge Survey. The National Hospital Discharge Survey collects data annually on inpatient discharges from a national probability sample of approximately 500 short-stay hospitals. We examined sepsis hospitalizations, defined by International Classification of Diseases, Ninth Revision, Clinical Modification codes, and compared sepsis hospitalization rates for 2 time periods after the issuance of IAP guidelines (1996-2001 and 2002-2006) with 1988-1995 using national natality data as the population denominator. We used Joinpoint (Surveillance Research Program, National Cancer Institute, Bethesda, Maryland) regression to assess the average annual percent change (AAPC) in rates.
RESULTS: Between 1988 and 2006, there were more than 2.5 million sepsis-related hospitalizations in infants aged <3 months (112 000-146 000 annually). In 2006, the sepsis hospitalization rate was 30.8/1000 births. The rate was more than 3 times higher in preterm infants compared with term infants (85.4/1000 preterm births vs 23.1/1000 term births). The AAPC in sepsis hospitalization rate was -3.6% (95% CI, -5.1% to 2.0%) [corrected] for term infants during 1996-2002 and did not change significantly after issuance of the revised 2002 guidelines. For preterm infants, the AAPC was -1.2% (95% CI, -2.2% to -0.1%) [corrected] annually from 1988 to 2006.
CONCLUSION: Clinical neonatal sepsis declined in the post-IAP era, mirroring trends observed in group B streptococcal early-onset neonatal sepsis surveillance. Preterm infants were affected disproportionately and exhibited a modest but steady decline in sepsis hospitalization rate. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22261508     DOI: 10.1016/j.jpeds.2011.12.023

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

Review 1.  Molecular-based screening for perinatal group B streptococcal infection: implications for prevention and therapy.

Authors:  Stéphane Emonet; Jacques Schrenzel; Begoña Martinez de Tejada
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

Review 2.  Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis.

Authors:  H Su; S-S Chang; C-M Han; K-Y Wu; M-C Li; C-Y Huang; C-L Lee; J-Y Wu; C-C Lee
Journal:  J Perinatol       Date:  2014-01-23       Impact factor: 2.521

Review 3.  Time for a neonatal-specific consensus definition for sepsis.

Authors:  James L Wynn; Hector R Wong; Thomas P Shanley; Matthew J Bizzarro; Lisa Saiman; Richard A Polin
Journal:  Pediatr Crit Care Med       Date:  2014-07       Impact factor: 3.624

4.  Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis.

Authors:  Cheryl B Lin; Christoph P Hornik; Reese Clark; C Michael Cotten; Daniel K Benjamin; Michael Cohen-Wolkoweiz; P Brian Smith; James L Wynn
Journal:  Early Hum Dev       Date:  2012-07-27       Impact factor: 2.079

Review 5.  Signaling pathways and intervention therapies in sepsis.

Authors:  Yun-Yu Zhang; Bo-Tao Ning
Journal:  Signal Transduct Target Ther       Date:  2021-11-25

6.  Accuracy of Complete Blood Cell Counts to Identify Febrile Infants 60 Days or Younger With Invasive Bacterial Infections.

Authors:  Andrea T Cruz; Prashant Mahajan; Bema K Bonsu; Jonathan E Bennett; Deborah A Levine; Elizabeth R Alpern; Lise E Nigrovic; Shireen M Atabaki; Daniel M Cohen; John M VanBuren; Octavio Ramilo; Nathan Kuppermann
Journal:  JAMA Pediatr       Date:  2017-11-06       Impact factor: 16.193

7.  Antibiotic Use Without Indication During Delivery Hospitalizations in the United States.

Authors:  Maria Andrikopoulou; Yongmei Huang; Cassandra R Duffy; Conrad N Stern-Ascher; Jason D Wright; Dena Goffman; Mary E DʼAlton; Alexander M Friedman
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

Review 8.  Defining neonatal sepsis.

Authors:  James L Wynn
Journal:  Curr Opin Pediatr       Date:  2016-04       Impact factor: 2.856

9.  Incidence of early-onset sepsis in infants born to women with clinical chorioamnionitis.

Authors:  Tara M Randis; Madeline Murguia Rice; Leslie Myatt; Alan T N Tita; Kenneth J Leveno; Uma M Reddy; Michael W Varner; John M Thorp; Brian M Mercer; Mara J Dinsmoor; Susan M Ramin; Marshall W Carpenter; Philip Samuels; Anthony Sciscione; Jorge E Tolosa; George Saade; Yoram Sorokin
Journal:  J Perinat Med       Date:  2018-10-25       Impact factor: 2.716

Review 10.  Antibiotic use and misuse during pregnancy and delivery: benefits and risks.

Authors:  Begoña Martinez de Tejada
Journal:  Int J Environ Res Public Health       Date:  2014-08-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.